R2D2 is a 5-year $3.3M NIH-funded trial led by Dr. Campbell on the effect of a pharmacist-based deprescribing intervention on older adult cognition and dementia risk.
![med safe logo](/lab/sites/default/files/inline-images/med-safe-logo.png)
Participants wanted!
If you would like to participate in this study, please contact us at bsafe@iu.edu